What Know About This Fund’s Exit From Ascendis Pharma
A notable fund liquidated its entire Ascendis Pharma stake, signaling a strategic rotation in a volatile biotech sect...
Identify whether a Backdoor Roth is right for you, focusing on income, taxes, and long-term retirement goals.
23,905 articlesA notable fund liquidated its entire Ascendis Pharma stake, signaling a strategic rotation in a volatile biotech sect...
Senior executives are increasingly deferring about $100,000 of pay into non-qualified plans to extend tax-advantaged ...
As Greg Abel steers Berkshire Hathaway's non-insurance businesses, Berkshire Hathaway Energy could emerge as a reliab...
This article breaks down the expected path for synopsys (snps) 2026 earnings, focusing on AI design driver demand, li...
A mid-sized fund has quietly built a sizable Porch Group position, signaling conviction in this tech-insurance combo....
As Neogen gears up for Q3 2026 earnings, investors are digging for signals beyond the headline numbers. This article ...
Quanex (NX) is navigating a housing cycle and raw material costs as it shapes its 2026 earnings. This guide breaks do...
Arista Networks and AudioCodes sit at different points in the networking landscape. This article breaks down their bu...
Analysts rolled out a fresh slate of calls on Block, Cognizant, First Solar and others as markets navigate midweek vo...
As silver prices drive market chatter in 2026, traders compare SIL and SILJ. The choice hinges on exposure to establi...
Citigroup and Wells Fargo chart different paths: one leans global and institutional, the other domestic and consumer-...
The private credit boom faces a real test as higher rates and shifting liquidity tighten the lending landscape. This ...